Antiviral activity of cationic amphiphilic drugs
Open accessThe DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
INTRODUCTION: Emerging and reemerging viral infections represent a major concern for human and veterinary public health and there is an urgent need for the development of broad-spectrum antivirals. Areas covered: A recent strategy in antiviral research is based on the identification of molecules targeting host functions required for infection of multiple viruses. A number of FDA-approved drugs used to treat several human diseases are cationic amphiphilic drugs (CADs) that have the ability to accumulate inside cells affecting several structures/functions hijacked by viruses during infection. In this review we summarized the CADs' chemical properties and effects on the cells and reported the main FDA-approved CADs that have been identified so far as potential antivirals in drug repurposing studies. Expert commentary: Although there have been concerns regarding the efficacy and the possible side effects of the off-label use of CADs as antivirals, they seem to represent a promising starting point for the development of broad-spectrum antiviral strategies. Further knowledge about their mechanism of action is required to improve their antiviral activity and to reduce the risk of side effects.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Impacts of biodiversity on the emergence and transmission of infectious diseases
Keesing, F., Belden, L. K., Daszak, P., Dobson, A., Harvell, C. D., Holt, R. D., Hudson, P., Jolles, A., Jones, K. E., Mitchell, C. E., et al. (2010) · Nature · doi:10.1038/nature09575 · Cited by 2,043 · cited 1×
“Due to their sporadic outbreaks in humans, these highly pathogenic viruses require a continuous surveillance activity which needs a significant effort of the National Health Systems and of the International Authorities [6] [7] [8] [9] [10] .”
BackgroundOrigins of major human infectious diseases
Wolfe, N. D., Dunavan, C. P., & Diamond, J. (2007) · Nature · doi:10.1038/nature05775 · Cited by 1,867 · cited 1×
“Due to their sporadic outbreaks in humans, these highly pathogenic viruses require a continuous surveillance activity which needs a significant effort of the National Health Systems and of the International Authorities [6] [7] [8] [9] [10] .”
BackgroundLu, F., Liang, Q., Abi-Mosleh, L., Das, A., De Brabander, J. K., Goldstein, J. L., & Brown, M. S. (2015) · eLife · doi:10.7554/elife.12177 · Cited by 333 · cited 1×
“NPC-1, its anti-EBOV activity seems to be independent by such an interaction and more likely due to U18666A pleiotropic effects on the LE/Lys system [23,98].”
BackgroundThe evolution of Ebola virus: Insights from the 2013-2016 epidemic
Holmes, E. C., Dudas, G., Rambaut, A., & Andersen, K. G. (2016) · Nature · doi:10.1038/nature19790 · Cited by 314 · cited 1×
“Due to climate and environmental changes, travel and trade globalization, infectious agents spread more rapidly and widely than in the last century [1] , as showed by the number of emerging and reemerging viral infections appeared since the 2000, such as the Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV), th…”
Background
Cited by
Chloroquine and hydroxychloroquine in covid-19
Ferner, R. E., & Aronson, J. K. (2020) · BMJ · doi:10.1136/bmj.m1432 · Cited by 403
Targeting lysosomes in human disease: from basic research to clinical applications
Cao, M., Luo, X., Wu, K., & He, X. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00778-y · Cited by 225
“As representative cationic amphiphilic drugs (CADs), CQ and its derivatives share a common structure of a side-chain with a cationic amine group, which allows them to accumulate within lysosomes after protonation, resulting in lysosomal deacidification.(5,26,198) In addition, CQ and HCQ have shown a strong ability of…”
BackgroundKonuma, T., Ogawa, K., & Okada, Y. (2021) · Human Molecular Genetics · doi:10.1093/hmg/ddab049 · Cited by 22
Yousef, M., Le, T. S., Zuo, J., Park, C., Chacra, N. B., Davies, N. M., & Löbenberg, R. (2023) · Research in Pharmaceutical Sciences · doi:10.4103/1735-5362.363591 · Cited by 10
“Therefore, lysosomotropic drugs have also been investigated to be potentially repurposed and therapeutically utilized for their antiviral properties (28).”
Background
Metadata
- Authors
- Salata, C., Calistri, A., Parolin, C., Baritussio, A., & Palù, G.
- Venue
- Expert Review of Anti-infective Therapy
- Publisher
- Informa UK Limited
- Published
- 2017-03-20
- Volume
- 15
- Issue
- 5
- Pages
- 483-492
- ISSN
- 1478-7210 (ISSN-L)
- 1744-8336
- OpenAlex
- W2597115993
- Cited by
- 140
- References
- 4
- FWCI
- 5.23
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Antiviral activity of cationic amphiphilic drugs. https://app.cochat.ai/papers/10.1080/14787210.2017.1305888
- The paper
- Salata, C., Calistri, A., Parolin, C., Baritussio, A., & Palù, G. (2017). Antiviral activity of cationic amphiphilic drugs. Expert Review of Anti-infective Therapy. https://doi.org/10.1080/14787210.2017.1305888
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.